CTSO vs DD · $28.8M cap vs P/E 127, rev $12.39B
Cytosorbents Crp (CTSO) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
CTSO does not have a complete income-statement cache yet.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CTSO currently screens at market cap $28.8M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CTSO and DD stock pages for the full models.
Not investment advice.